Index by author

April 01, 1996; Volume 7,Issue 4

A

  1. Acott, P D

    1. Thyroid hormone modulation of glucocorticoid-induced polycystic kidney disease.
      J F Crocker, M E Schenk, D A Hamilton, D E Cole, A T McDonald and P D Acott
      JASN April 1996, 7 (4) 633-634;

  2. Akalin, E

    1. Colchicine interferes with L-selectin and leukocyte function-associated antigen-1 expression on human T lymphocytes and inhibits T cell activation.
      N Perico, D Ostermann, M Bontempeill, M Morigi, C S Amuchastegui, C Zoja, E Akalin, M H Sayegh and G Remuzzi
      JASN April 1996, 7 (4) 594-601;

  3. Amuchastegui, C S

    1. Colchicine interferes with L-selectin and leukocyte function-associated antigen-1 expression on human T lymphocytes and inhibits T cell activation.
      N Perico, D Ostermann, M Bontempeill, M Morigi, C S Amuchastegui, C Zoja, E Akalin, M H Sayegh and G Remuzzi
      JASN April 1996, 7 (4) 594-601;

  4. Apperloo, A J

    1. Precision of glomerular filtration rate determinations for long-term slope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I-hippuran.
      A J Apperloo, D de Zeeuw, A J Donker and P E de Jong
      JASN April 1996, 7 (4) 567-572;

  5. Argilés, A

    1. Low-calcium dialysate worsens secondary hyperparathyroidism.
      A Argilés and C M Mion
      JASN April 1996, 7 (4) 635-636;

  6. Asplin, J R

    1. Normal calcium oxalate crystal growth inhibition in severe calcium oxalate nephrolithiasis.
      J L Porile, J R Asplin, J H Parks, Y Nakagawa and F L Coe
      JASN April 1996, 7 (4) 602-607;

B

  1. Baggio, B

    1. The abnormal red-cell oxalate transport is a risk factor for idiopathic calcium nephrolithiasis: a prospective study.
      G Gambaro, F Marchini, A Piccoli, M A Nassuato, F Bilora and B Baggio
      JASN April 1996, 7 (4) 608-612;
    2. Anomalous phospholipid n-6 polyunsaturated fatty acid composition in idiopathic calcium nephrolithiasis.
      B Baggio, G Gambaro, S Zambon, F Marchini, A Bassi, L Bordin, G Clari and E Manzato
      JASN April 1996, 7 (4) 613-620;

  2. Barrientos, A

    1. Abnormalities of heme biosynthesis in experimental acute renal failure.
      A Fontanellas, J A Herrero, J I Trobo, M J Morán, F Coronel, A Barrientos and R E de Salamanca
      JASN April 1996, 7 (4) 628-632;

  3. Bassi, A

    1. Anomalous phospholipid n-6 polyunsaturated fatty acid composition in idiopathic calcium nephrolithiasis.
      B Baggio, G Gambaro, S Zambon, F Marchini, A Bassi, L Bordin, G Clari and E Manzato
      JASN April 1996, 7 (4) 613-620;

  4. Bilora, F

    1. The abnormal red-cell oxalate transport is a risk factor for idiopathic calcium nephrolithiasis: a prospective study.
      G Gambaro, F Marchini, A Piccoli, M A Nassuato, F Bilora and B Baggio
      JASN April 1996, 7 (4) 608-612;

  5. Bontempeill, M

    1. Colchicine interferes with L-selectin and leukocyte function-associated antigen-1 expression on human T lymphocytes and inhibits T cell activation.
      N Perico, D Ostermann, M Bontempeill, M Morigi, C S Amuchastegui, C Zoja, E Akalin, M H Sayegh and G Remuzzi
      JASN April 1996, 7 (4) 594-601;

  6. Bordin, L

    1. Anomalous phospholipid n-6 polyunsaturated fatty acid composition in idiopathic calcium nephrolithiasis.
      B Baggio, G Gambaro, S Zambon, F Marchini, A Bassi, L Bordin, G Clari and E Manzato
      JASN April 1996, 7 (4) 613-620;

  7. Bunchman, T E

    1. Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis.
      M J Gregory, W E Smoyer, A Sedman, D B Kershaw, R P Valentini, K Johnson and T E Bunchman
      JASN April 1996, 7 (4) 543-549;

C

  1. Chandran, P K

    1. Recommendations for the initiation of dialysis.
      P K Chandran
      JASN April 1996, 7 (4) 635;

  2. Clari, G

    1. Anomalous phospholipid n-6 polyunsaturated fatty acid composition in idiopathic calcium nephrolithiasis.
      B Baggio, G Gambaro, S Zambon, F Marchini, A Bassi, L Bordin, G Clari and E Manzato
      JASN April 1996, 7 (4) 613-620;

  3. Coe, F L

    1. Normal calcium oxalate crystal growth inhibition in severe calcium oxalate nephrolithiasis.
      J L Porile, J R Asplin, J H Parks, Y Nakagawa and F L Coe
      JASN April 1996, 7 (4) 602-607;

  4. Cole, D E

    1. Thyroid hormone modulation of glucocorticoid-induced polycystic kidney disease.
      J F Crocker, M E Schenk, D A Hamilton, D E Cole, A T McDonald and P D Acott
      JASN April 1996, 7 (4) 633-634;

  5. Coronel, F

    1. Abnormalities of heme biosynthesis in experimental acute renal failure.
      A Fontanellas, J A Herrero, J I Trobo, M J Morán, F Coronel, A Barrientos and R E de Salamanca
      JASN April 1996, 7 (4) 628-632;

  6. Couser, W G

    1. Phosphodiesterase inhibitors correct resistance to natriuretic peptides in rats with Heymann Nephritis.
      J P Valentin, W Z Ying, L A Sechi, K T Ling, C Qiu, W G Couser and M H Humphreys
      JASN April 1996, 7 (4) 582-593;

  7. Crocker, J F

    1. Thyroid hormone modulation of glucocorticoid-induced polycystic kidney disease.
      J F Crocker, M E Schenk, D A Hamilton, D E Cole, A T McDonald and P D Acott
      JASN April 1996, 7 (4) 633-634;

D

  1. Daha, M R

    1. Both IgG- and C1q-receptors play a role in the enhanced binding of IgG complexes to human mesangial cells.
      M E van den Dobbelsteen, F J van der Woude, W E Schroeijers, N Klar-Mohamad, L A van Es and M R Daha
      JASN April 1996, 7 (4) 573-581;

  2. de Jong, P E

    1. Precision of glomerular filtration rate determinations for long-term slope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I-hippuran.
      A J Apperloo, D de Zeeuw, A J Donker and P E de Jong
      JASN April 1996, 7 (4) 567-572;

  3. de Ridder, L

    1. Beneficial influence of ketanserin on autoregulation of blood flow in post-ischemic kidneys.
      M Verbeke, B Smöllich, J van de Voorde, L de Ridder and N Lameire
      JASN April 1996, 7 (4) 621-627;

  4. de Salamanca, R E

    1. Abnormalities of heme biosynthesis in experimental acute renal failure.
      A Fontanellas, J A Herrero, J I Trobo, M J Morán, F Coronel, A Barrientos and R E de Salamanca
      JASN April 1996, 7 (4) 628-632;

  5. de Zeeuw, D

    1. Precision of glomerular filtration rate determinations for long-term slope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I-hippuran.
      A J Apperloo, D de Zeeuw, A J Donker and P E de Jong
      JASN April 1996, 7 (4) 567-572;

  6. Donker, A J

    1. Precision of glomerular filtration rate determinations for long-term slope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I-hippuran.
      A J Apperloo, D de Zeeuw, A J Donker and P E de Jong
      JASN April 1996, 7 (4) 567-572;

F

  1. Feldman, H I

    1. Hemodialysis vascular access morbidity.
      H I Feldman, S Kobrin and A Wasserstein
      JASN April 1996, 7 (4) 523-535;

  2. Fontanellas, A

    1. Abnormalities of heme biosynthesis in experimental acute renal failure.
      A Fontanellas, J A Herrero, J I Trobo, M J Morán, F Coronel, A Barrientos and R E de Salamanca
      JASN April 1996, 7 (4) 628-632;

G

  1. Gambaro, G

    1. The abnormal red-cell oxalate transport is a risk factor for idiopathic calcium nephrolithiasis: a prospective study.
      G Gambaro, F Marchini, A Piccoli, M A Nassuato, F Bilora and B Baggio
      JASN April 1996, 7 (4) 608-612;
    2. Anomalous phospholipid n-6 polyunsaturated fatty acid composition in idiopathic calcium nephrolithiasis.
      B Baggio, G Gambaro, S Zambon, F Marchini, A Bassi, L Bordin, G Clari and E Manzato
      JASN April 1996, 7 (4) 613-620;

  2. Gregory, M J

    1. Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis.
      M J Gregory, W E Smoyer, A Sedman, D B Kershaw, R P Valentini, K Johnson and T E Bunchman
      JASN April 1996, 7 (4) 543-549;

H

  1. Hamilton, D A

    1. Thyroid hormone modulation of glucocorticoid-induced polycystic kidney disease.
      J F Crocker, M E Schenk, D A Hamilton, D E Cole, A T McDonald and P D Acott
      JASN April 1996, 7 (4) 633-634;

  2. Herrero, J A

    1. Abnormalities of heme biosynthesis in experimental acute renal failure.
      A Fontanellas, J A Herrero, J I Trobo, M J Morán, F Coronel, A Barrientos and R E de Salamanca
      JASN April 1996, 7 (4) 628-632;

  3. Humphreys, M H

    1. Phosphodiesterase inhibitors correct resistance to natriuretic peptides in rats with Heymann Nephritis.
      J P Valentin, W Z Ying, L A Sechi, K T Ling, C Qiu, W G Couser and M H Humphreys
      JASN April 1996, 7 (4) 582-593;

J

  1. Johnson, K

    1. Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis.
      M J Gregory, W E Smoyer, A Sedman, D B Kershaw, R P Valentini, K Johnson and T E Bunchman
      JASN April 1996, 7 (4) 543-549;

K

  1. Kershaw, D B

    1. Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis.
      M J Gregory, W E Smoyer, A Sedman, D B Kershaw, R P Valentini, K Johnson and T E Bunchman
      JASN April 1996, 7 (4) 543-549;

  2. Klar-Mohamad, N

    1. Both IgG- and C1q-receptors play a role in the enhanced binding of IgG complexes to human mesangial cells.
      M E van den Dobbelsteen, F J van der Woude, W E Schroeijers, N Klar-Mohamad, L A van Es and M R Daha
      JASN April 1996, 7 (4) 573-581;

  3. Kobrin, S

    1. Hemodialysis vascular access morbidity.
      H I Feldman, S Kobrin and A Wasserstein
      JASN April 1996, 7 (4) 523-535;

L

  1. Lameire, N

    1. Beneficial influence of ketanserin on autoregulation of blood flow in post-ischemic kidneys.
      M Verbeke, B Smöllich, J van de Voorde, L de Ridder and N Lameire
      JASN April 1996, 7 (4) 621-627;

  2. Ling, K T

    1. Phosphodiesterase inhibitors correct resistance to natriuretic peptides in rats with Heymann Nephritis.
      J P Valentin, W Z Ying, L A Sechi, K T Ling, C Qiu, W G Couser and M H Humphreys
      JASN April 1996, 7 (4) 582-593;

M

  1. Manzato, E

    1. Anomalous phospholipid n-6 polyunsaturated fatty acid composition in idiopathic calcium nephrolithiasis.
      B Baggio, G Gambaro, S Zambon, F Marchini, A Bassi, L Bordin, G Clari and E Manzato
      JASN April 1996, 7 (4) 613-620;

  2. Marchini, F

    1. The abnormal red-cell oxalate transport is a risk factor for idiopathic calcium nephrolithiasis: a prospective study.
      G Gambaro, F Marchini, A Piccoli, M A Nassuato, F Bilora and B Baggio
      JASN April 1996, 7 (4) 608-612;
    2. Anomalous phospholipid n-6 polyunsaturated fatty acid composition in idiopathic calcium nephrolithiasis.
      B Baggio, G Gambaro, S Zambon, F Marchini, A Bassi, L Bordin, G Clari and E Manzato
      JASN April 1996, 7 (4) 613-620;

  3. McDonald, A T

    1. Thyroid hormone modulation of glucocorticoid-induced polycystic kidney disease.
      J F Crocker, M E Schenk, D A Hamilton, D E Cole, A T McDonald and P D Acott
      JASN April 1996, 7 (4) 633-634;

  4. Mion, C M

    1. Low-calcium dialysate worsens secondary hyperparathyroidism.
      A Argilés and C M Mion
      JASN April 1996, 7 (4) 635-636;

  5. Morán, M J

    1. Abnormalities of heme biosynthesis in experimental acute renal failure.
      A Fontanellas, J A Herrero, J I Trobo, M J Morán, F Coronel, A Barrientos and R E de Salamanca
      JASN April 1996, 7 (4) 628-632;

  6. Morigi, M

    1. Colchicine interferes with L-selectin and leukocyte function-associated antigen-1 expression on human T lymphocytes and inhibits T cell activation.
      N Perico, D Ostermann, M Bontempeill, M Morigi, C S Amuchastegui, C Zoja, E Akalin, M H Sayegh and G Remuzzi
      JASN April 1996, 7 (4) 594-601;

N

  1. Nakagawa, Y

    1. Normal calcium oxalate crystal growth inhibition in severe calcium oxalate nephrolithiasis.
      J L Porile, J R Asplin, J H Parks, Y Nakagawa and F L Coe
      JASN April 1996, 7 (4) 602-607;

  2. Nassuato, M A

    1. The abnormal red-cell oxalate transport is a risk factor for idiopathic calcium nephrolithiasis: a prospective study.
      G Gambaro, F Marchini, A Piccoli, M A Nassuato, F Bilora and B Baggio
      JASN April 1996, 7 (4) 608-612;

O

  1. Ostermann, D

    1. Colchicine interferes with L-selectin and leukocyte function-associated antigen-1 expression on human T lymphocytes and inhibits T cell activation.
      N Perico, D Ostermann, M Bontempeill, M Morigi, C S Amuchastegui, C Zoja, E Akalin, M H Sayegh and G Remuzzi
      JASN April 1996, 7 (4) 594-601;

P

  1. Parks, J H

    1. Normal calcium oxalate crystal growth inhibition in severe calcium oxalate nephrolithiasis.
      J L Porile, J R Asplin, J H Parks, Y Nakagawa and F L Coe
      JASN April 1996, 7 (4) 602-607;

  2. Perico, N

    1. Colchicine interferes with L-selectin and leukocyte function-associated antigen-1 expression on human T lymphocytes and inhibits T cell activation.
      N Perico, D Ostermann, M Bontempeill, M Morigi, C S Amuchastegui, C Zoja, E Akalin, M H Sayegh and G Remuzzi
      JASN April 1996, 7 (4) 594-601;

  3. Piccoli, A

    1. The abnormal red-cell oxalate transport is a risk factor for idiopathic calcium nephrolithiasis: a prospective study.
      G Gambaro, F Marchini, A Piccoli, M A Nassuato, F Bilora and B Baggio
      JASN April 1996, 7 (4) 608-612;

  4. Porile, J L

    1. Normal calcium oxalate crystal growth inhibition in severe calcium oxalate nephrolithiasis.
      J L Porile, J R Asplin, J H Parks, Y Nakagawa and F L Coe
      JASN April 1996, 7 (4) 602-607;

Q

  1. Qiu, C

    1. Phosphodiesterase inhibitors correct resistance to natriuretic peptides in rats with Heymann Nephritis.
      J P Valentin, W Z Ying, L A Sechi, K T Ling, C Qiu, W G Couser and M H Humphreys
      JASN April 1996, 7 (4) 582-593;

R

  1. Remuzzi, G

    1. Colchicine interferes with L-selectin and leukocyte function-associated antigen-1 expression on human T lymphocytes and inhibits T cell activation.
      N Perico, D Ostermann, M Bontempeill, M Morigi, C S Amuchastegui, C Zoja, E Akalin, M H Sayegh and G Remuzzi
      JASN April 1996, 7 (4) 594-601;

S

  1. Sayegh, M H

    1. Colchicine interferes with L-selectin and leukocyte function-associated antigen-1 expression on human T lymphocytes and inhibits T cell activation.
      N Perico, D Ostermann, M Bontempeill, M Morigi, C S Amuchastegui, C Zoja, E Akalin, M H Sayegh and G Remuzzi
      JASN April 1996, 7 (4) 594-601;

  2. Schenk, M E

    1. Thyroid hormone modulation of glucocorticoid-induced polycystic kidney disease.
      J F Crocker, M E Schenk, D A Hamilton, D E Cole, A T McDonald and P D Acott
      JASN April 1996, 7 (4) 633-634;

  3. Schroeijers, W E

    1. Both IgG- and C1q-receptors play a role in the enhanced binding of IgG complexes to human mesangial cells.
      M E van den Dobbelsteen, F J van der Woude, W E Schroeijers, N Klar-Mohamad, L A van Es and M R Daha
      JASN April 1996, 7 (4) 573-581;

  4. Sechi, L A

    1. Phosphodiesterase inhibitors correct resistance to natriuretic peptides in rats with Heymann Nephritis.
      J P Valentin, W Z Ying, L A Sechi, K T Ling, C Qiu, W G Couser and M H Humphreys
      JASN April 1996, 7 (4) 582-593;

  5. Sedman, A

    1. Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis.
      M J Gregory, W E Smoyer, A Sedman, D B Kershaw, R P Valentini, K Johnson and T E Bunchman
      JASN April 1996, 7 (4) 543-549;

  6. Smöllich, B

    1. Beneficial influence of ketanserin on autoregulation of blood flow in post-ischemic kidneys.
      M Verbeke, B Smöllich, J van de Voorde, L de Ridder and N Lameire
      JASN April 1996, 7 (4) 621-627;

  7. Smoyer, W E

    1. Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis.
      M J Gregory, W E Smoyer, A Sedman, D B Kershaw, R P Valentini, K Johnson and T E Bunchman
      JASN April 1996, 7 (4) 543-549;

  8. Sullivan, E K

    1. Higher maintenance cyclosporine dose decreases the risk of graft failure in North American children: a report of the North American Pediatric Renal Transplant Cooperative Study.
      A Tejani and E K Sullivan
      JASN April 1996, 7 (4) 550-555;

T

  1. Tejani, A

    1. Higher maintenance cyclosporine dose decreases the risk of graft failure in North American children: a report of the North American Pediatric Renal Transplant Cooperative Study.
      A Tejani and E K Sullivan
      JASN April 1996, 7 (4) 550-555;

  2. Trobo, J I

    1. Abnormalities of heme biosynthesis in experimental acute renal failure.
      A Fontanellas, J A Herrero, J I Trobo, M J Morán, F Coronel, A Barrientos and R E de Salamanca
      JASN April 1996, 7 (4) 628-632;

V

  1. Valentin, J P

    1. Phosphodiesterase inhibitors correct resistance to natriuretic peptides in rats with Heymann Nephritis.
      J P Valentin, W Z Ying, L A Sechi, K T Ling, C Qiu, W G Couser and M H Humphreys
      JASN April 1996, 7 (4) 582-593;

  2. Valentini, R P

    1. Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis.
      M J Gregory, W E Smoyer, A Sedman, D B Kershaw, R P Valentini, K Johnson and T E Bunchman
      JASN April 1996, 7 (4) 543-549;

  3. van den Dobbelsteen, M E

    1. Both IgG- and C1q-receptors play a role in the enhanced binding of IgG complexes to human mesangial cells.
      M E van den Dobbelsteen, F J van der Woude, W E Schroeijers, N Klar-Mohamad, L A van Es and M R Daha
      JASN April 1996, 7 (4) 573-581;

  4. van der Woude, F J

    1. Both IgG- and C1q-receptors play a role in the enhanced binding of IgG complexes to human mesangial cells.
      M E van den Dobbelsteen, F J van der Woude, W E Schroeijers, N Klar-Mohamad, L A van Es and M R Daha
      JASN April 1996, 7 (4) 573-581;

  5. van de Voorde, J

    1. Beneficial influence of ketanserin on autoregulation of blood flow in post-ischemic kidneys.
      M Verbeke, B Smöllich, J van de Voorde, L de Ridder and N Lameire
      JASN April 1996, 7 (4) 621-627;

  6. van Es, L A

    1. Both IgG- and C1q-receptors play a role in the enhanced binding of IgG complexes to human mesangial cells.
      M E van den Dobbelsteen, F J van der Woude, W E Schroeijers, N Klar-Mohamad, L A van Es and M R Daha
      JASN April 1996, 7 (4) 573-581;

  7. Veis, J H

    1. Antibiotic-resistant endocarditis in a hemodialysis patient.
      R Vijayvargiya and J H Veis
      JASN April 1996, 7 (4) 536-542;

  8. Verbeke, M

    1. Beneficial influence of ketanserin on autoregulation of blood flow in post-ischemic kidneys.
      M Verbeke, B Smöllich, J van de Voorde, L de Ridder and N Lameire
      JASN April 1996, 7 (4) 621-627;

  9. Vijayvargiya, R

    1. Antibiotic-resistant endocarditis in a hemodialysis patient.
      R Vijayvargiya and J H Veis
      JASN April 1996, 7 (4) 536-542;

W

  1. Wasserstein, A

    1. Hemodialysis vascular access morbidity.
      H I Feldman, S Kobrin and A Wasserstein
      JASN April 1996, 7 (4) 523-535;

Y

  1. Ying, W Z

    1. Phosphodiesterase inhibitors correct resistance to natriuretic peptides in rats with Heymann Nephritis.
      J P Valentin, W Z Ying, L A Sechi, K T Ling, C Qiu, W G Couser and M H Humphreys
      JASN April 1996, 7 (4) 582-593;

Z

  1. Zambon, S

    1. Anomalous phospholipid n-6 polyunsaturated fatty acid composition in idiopathic calcium nephrolithiasis.
      B Baggio, G Gambaro, S Zambon, F Marchini, A Bassi, L Bordin, G Clari and E Manzato
      JASN April 1996, 7 (4) 613-620;

  2. Zoja, C

    1. Colchicine interferes with L-selectin and leukocyte function-associated antigen-1 expression on human T lymphocytes and inhibits T cell activation.
      N Perico, D Ostermann, M Bontempeill, M Morigi, C S Amuchastegui, C Zoja, E Akalin, M H Sayegh and G Remuzzi
      JASN April 1996, 7 (4) 594-601;
Back to top

In this issue

View Selected Citations (0)